首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1863963

生殖遺傳學市場：按技術、應用、樣本類型、最終用戶、分析方法和地區分類

Reproductive Genetics Market, By Technology, By Application, By Sample Type, By End User, By Methodology, By Geography

出版日期: 2025年10月15日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年生殖遺傳學市場規模預計為 73.1 億美元，預計到 2032 年將達到 166.7 億美元，2025 年至 2032 年的複合年成長率為 12.5%。

分析範圍		分析詳情
基準年	2024	市場規模（2025 年）	73.1億美元
效能數據	2020-2024	預測期	2025-2032
預測期（2025-2032 年）複合年成長率	12.50%	預計金額（2032 年）	166.7億美元

全球生殖遺傳學市場是整個醫療產業中一個快速發展的領域，涵蓋了旨在評估生殖健康和不孕症治療結果的先進基因檢測和篩檢技術。

這個專業市場專注於基因分析服務和產品，旨在幫助醫療保健提供者、生育診所和患者就生育計劃、妊娠管理和遺傳風險評估做出明智的決定。生殖遺傳學整合了尖端的分子診斷、基因測序技術和生物資訊平台，以識別可能影響生育成功率和後代健康的染色體異常、遺傳性疾病和基因疾病。

該市場涵蓋了各種調查方法胚胎著床前遺傳學檢測 (PGT)、非侵入性產前檢測 (NIPT)、帶因者篩檢、基因諮詢服務等。隨著世界各地的醫療保健系統越來越重視個人化和預防性醫療，生殖遺傳學已成為現代不孕症治療和產前護理通訊協定的關鍵組成部分。

市場動態

全球生殖遺傳學市場的主要驅動力是幾個關鍵因素，這些因素持續推動其在已開發和新興醫療保健市場的擴張。遺傳疾病和染色體異常的日益普遍，以及全球孕產婦人口老化的趨勢，顯著增加了對全面基因篩檢服務的需求。

高齡生產，會增加遺傳併發症的風險，因此醫療機構建議進行常規基因檢測。次世代定序（ NGS）、微陣列分析和基於人工智慧的診斷平台等技術的進步，顯著提高了檢測的準確性，同時降低了成本和縮短了周轉時間，使更多患者能夠獲得這些服務。

隨著醫護人員和病患對早期基因檢測益處的認知不斷提高，生育診所和醫療機構的基因檢測普及率也不斷提高。然而，仍有許多阻礙因素，例如先進基因檢測程序的高昂費用，這可能會限制發展中國家患者或缺乏全面醫療保險的患者獲得檢測機會。

各國複雜的監管規定和核准流程差異可能會阻礙新技術進入市場，並延遲產品上市。此外，圍繞基因檢測的倫理問題，包括基因歧視和基因資訊隱私等問題，可能會讓某些患者群體猶豫不決。

本報告的主要特點

本報告對全球生殖遺傳學市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模和複合年成長率，以 2024 年為基準年。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
全球生殖遺傳學市場的主要企業將根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作關係、市場擴張和行銷策略做出明智的決策。
《全球生殖遺傳學市場》報告涵蓋了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過各種用於分析全球生殖遺傳學市場的策略矩陣，更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 7.31 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.50%	2032 Value Projection:	USD 16.67 Bn

This specialized market focuses on genetic analysis services and products that help healthcare providers, fertility clinics, and patients make informed decisions regarding reproductive planning, pregnancy management, and genetic risk assessment. Reproductive genetics integrates cutting-edge molecular diagnostics, genomic sequencing technologies, and bioinformatics platforms to identify chromosomal abnormalities, genetic disorders, and hereditary conditions that may impact reproductive success or offspring health.

The market encompasses various testing methodologies including preimplantation genetic testing (PGT), non-invasive prenatal testing (NIPT), carrier screening, and genetic counseling services. As healthcare systems worldwide increasingly prioritize personalized medicine and preventive care, reproductive genetics has emerged as a critical component in modern fertility treatments and prenatal care protocols.

Market Dynamics

The global reproductive genetics market is primarily driven by several compelling factors that continue to fuel its expansion across developed and emerging healthcare markets. The increasing prevalence of genetic disorders and chromosomal abnormalities, combined with rising maternal age trends globally, has significantly heightened the demand for comprehensive genetic screening services.

Advanced maternal age, particularly pregnancies after 35 years, carries elevated risks of genetic complications, driving healthcare providers to recommend routine genetic testing protocols. Technological breakthroughs in next-generation sequencing (NGS), microarray analysis, and artificial intelligence-powered diagnostic platforms have substantially improved testing accuracy while reducing costs and turnaround times, making these services more accessible to broader patient populations.

Growing awareness among healthcare professionals and patients regarding the benefits of early genetic detection has fostered increased adoption rates across fertility clinics and healthcare institutions. However, the market faces notable restraints including high costs associated with advanced genetic testing procedures, which may limit accessibility for patients in developing regions or those without comprehensive insurance coverage.

Regulatory complexities and varying approval processes across different countries can impede market entry for new technologies and delay product launches. Additionally, ethical concerns surrounding genetic testing, including issues related to genetic discrimination and privacy of genetic information, may create hesitancy among certain patient demographics.

Key Features of the Study

This report provides in-depth analysis of the global reproductive genetics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global reproductive genetics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Agilent Technologies, Revvity (PerkinElmer), Bio-Rad Laboratories, Pacific Biosciences, Oxford Nanopore Technologies, MGI Tech, CooperSurgical, Hamilton Thorne, Vitrolife, Takara Bio, and Promega Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global reproductive genetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reproductive genetics market

Market Segmentation

Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Preimplantation Genetic Testing (PGT)
- PGT-A (Aneuploidy)
- PGT-M (Monogenic Disorders)
- PGT-SR (Structural Rearrangements)
- Carrier Screening
- Targeted Mutation Panels
- Expanded Carrier Screening
- Prenatal Genetic Testing
- Non-Invasive Prenatal Testing (NIPT)
- Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
- Newborn Genetic Testing
- Whole Exome Sequencing
- Targeted Gene Panels
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Infertility and IVF Programs
- Genetic Disease Risk Assessment
- Chromosomal Abnormality Detection
- Fetal Health Screening
- Inherited Disorder Diagnosis
- Recurrent Pregnancy Loss Investigation
Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Instruments and Systems
- Sequencers
- PCR Systems
- Microarray Platforms
- Consumables and Reagents
- DNA Extraction Kits
- Amplification Reagents
- Hybridization Probes
- Software and Services
- Genetic Data Analysis Tools
- Counseling and Interpretation Services
Sample Type Insights (Revenue, USD Bn, 2020 - 2032)
- Embryo
- Amniotic Fluid
- Maternal Blood
- Buccal Swab
- Cord Blood
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Fertility Clinics and IVF Centers
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Genetic Counseling Centers
Methodology Insights (Revenue, USD Bn, 2020 - 2032)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In Situ Hybridization (FISH)
- Comparative Genomic Hybridization (CGH)
- Microarray Analysis
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Illumina
- Thermo Fisher Scientific
- Roche Diagnostics
- QIAGEN
- Agilent Technologies
- Revvity (PerkinElmer)
- Bio-Rad Laboratories
- Pacific Biosciences
- Oxford Nanopore Technologies
- MGI Tech
- CooperSurgical
- Hamilton Thorne
- Vitrolife
- Takara Bio
- Promega Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Reproductive Genetics Market, By Technology
- Global Reproductive Genetics Market, By Application
- Global Reproductive Genetics Market, By Product Type
- Global Reproductive Genetics Market, By Sample Type
- Global Reproductive Genetics Market, By End User
- Global Reproductive Genetics Market, By Methodology
- Global Reproductive Genetics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Reproductive Genetics Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Preimplantation Genetic Testing (PGT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - PGT-A (Aneuploidy)
  - PGT-M (Monogenic Disorders)
  - PGT-SR (Structural Rearrangements)
Carrier Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Targeted Mutation Panels
  - Expanded Carrier Screening
Prenatal Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Non-Invasive Prenatal Testing (NIPT)
  - Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
Newborn Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Whole Exome Sequencing
  - Targeted Gene Panels

5. Global Reproductive Genetics Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Infertility and IVF Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetic Disease Risk Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chromosomal Abnormality Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fetal Health Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inherited Disorder Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recurrent Pregnancy Loss Investigation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Reproductive Genetics Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Instruments and Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sequencers
PCR Systems
Microarray Platforms
Consumables and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
DNA Extraction Kits
Amplification Reagents
Hybridization Probes
Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetic Data Analysis Tools
Counseling and Interpretation Services

7. Global Reproductive Genetics Market, By Sample Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Embryo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Amniotic Fluid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Maternal Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Buccal Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cord Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Reproductive Genetics Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Fertility Clinics and IVF Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetic Counseling Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Reproductive Genetics Market, By Methodology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fluorescence In Situ Hybridization (FISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Comparative Genomic Hybridization (CGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microarray Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Reproductive Genetics Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Revvity (PerkinElmer)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacific Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MGI Tech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CooperSurgical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hamilton Thorne
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vitrolife
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies